Investors Purchase High Volume of Leap Therapeutics Call Options (NASDAQ:LPTX)

Leap Therapeutics, Inc. (NASDAQ:LPTX) was the target of unusually large options trading activity on Thursday. Stock investors bought 5,907 call options on the stock. This is an increase of approximately 546% compared to the average volume of 914 call options.

Leap Therapeutics Stock Performance

NASDAQ:LPTX traded up $1.61 during trading hours on Thursday, reaching $2.05. 760,562,526 shares of the stock were exchanged.

Leap Therapeutics Company Profile

Leap Therapeutics, Inc, a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers.